Back

Protein kinase C eta enhances Golgi-localized signaling and is associated with Alzheimer's disease using a recessive mode of inheritance

Gauron, M. C.; Prokopenko, D.; Lee, S.; Wolfe, S. A.; Hecker, J.; Willett, J.; Waqas, M.; Lorden, G.; Yang, Y.; Mayfield, J. E.; Castanho, I.; Mullin, K.; Morgan, S.; Hahn, G.; Demeo, D. L.; Hide, W.; Bertram, L.; Lange, C.; Newton, A. C.; Tanzi, R. E.

2025-05-14 neurology
10.1101/2025.05.13.25327562 medRxiv
Show abstract

The identification of Alzheimers disease (AD)-associated genomic variants has provided powerful insight into disease etiology. Genome-wide association studies (GWAS) for AD have successfully identified new targets but have almost exclusively utilized additive genetic models. Here, we performed a family-based GWAS under a recessive inheritance model using whole genome sequencing from families affected by AD. We found that the variant, rs7161410, located in an intron of the PRKCH gene, encoding protein kinase C eta (PKC), was associated with AD risk (p-value=1.41 x 10-7). Further analysis revealed a rare PRKCH missense mutation K65R in linkage disequilibrium with rs7161410, which was present in homozygous carriers of the rs7161410 risk allele. We show that this mutation leads to enhanced localization and signaling of PKC at the Golgi. The novel genetically-validated association of aberrant PKC signaling with AD opens avenues for new therapeutic targets aimed at prevention and treatment. One Sentence SummaryProtein kinase C eta enhances Golgi-localized signaling and is associated with Alzheimers disease.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.